TITLE

Accepting the risks

AUTHOR(S)
Freeman, Laurie
PUB. DATE
April 2000
SOURCE
Advertising Age;4/3/2000, Vol. 71 Issue 14, pS14
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the United States Food and Drug Administration's issuance of rules requiring drug advertisements to disclose side effects associated with drug. Final guidance for consumer-directed television advertising; Effectiveness of television commercials in communicating risks associated with prescription drugs.
ACCESSION #
2990244

 

Related Articles

  • Direct-to-Lou.  // Pharmaceutical Executive;Nov99, Vol. 19 Issue 11, p118 

    Examines direct-to-consumer topics in the ever-changing regulatory policies in the United States pharmaceutical industry. Internet advertising in the pharmaceutical industry; Decline in the need for the US Food and Drug Administration Guidance; Frameworks of the FDA provided by the...

  • No FDA love for Viagra Valentine's ads. Dickinson, James G. // Medical Marketing & Media;Apr2000, Vol. 35 Issue 4, p42 

    Deals with the disapproval of United States drug firm Pfizer's Viagra Valentine advertisements by the US Food and Drug Administration.

  • Patients and Pharmaceutical Industry Benefit from FDA Broadcase Guidance.  // Pharmaceutical Executive;Oct99, Vol. 19 Issue 10, p92 

    Reports the revisions made by the United States Food and Drug Administration on the guidance for broadcast advertising in the pharmaceutical industry. Guidance requirements for broadcast advertisements; Highlights on the guidance.

  • FDA field targets ADR submissions. James G., Dickinson // Medical Marketing & Media;Oct97, Vol. 32 Issue 10, p30 

    Reports on the US Food and Drug Administration field compliance program for drug firms with a history of adverse drug reaction reporting problems. Examination of completion and accuracy of ADR submissions; Internet address of the compliance program.

  • FDA `All Shook Up' about Prevacid Commercials. Mordock, Jeff // Pharmaceutical Executive;May2000, Vol. 20 Issue 5, p128 

    Reports on the warning issued by the United States Food and Drug Administration's Division of Drug Marketing, Advertising, and Communications, in relation to the advertisement aired by TAP Pharmaceuticals for its heartburn medicine Prevacid. Serious concern aired by the agency; Why the...

  • Prevention: Today's DTC Arms Critics. Breitstein, Joanna; Shalo, Sibyl // Pharmaceutical Executive;May2001, Vol. 21 Issue 5, p92 

    Cites the criticism of the Department of Drug Marketing, Advertising, and Communications of the United States Food and Drug Administration on the direct-to-consumer (DTC) advertising practices of the pharmaceutical industry. Results of a survey on consumers' reaction to DTC advertising; Impact...

  • FDA takes the mystery out of TV ads. Liebman, Milton // Medical Marketing & Media;Sep97, Vol. 32 Issue 9, p34 

    Examines the possible impact of drug industry promotion of the US Food and Drug Administration's new guidelines for television advertising of direct-to-consumer drugs. Communication of product information in a consumer-friendly manner; Requirement of a risk-disclosing statement; Predicted...

  • Final FDA broadcast rules due, '99 starts with warning to Novartis.  // Medical Marketing & Media;Apr99, Vol. 34 Issue 4, p24 

    Reports on the United States Food and Drug Administration's television broadcast guidelines covering television advertising. Publication of the guidelines; Warning to Novartis.

  • DTC firms abuse FDA `reminder' leniency. Dickinson, James G. // Medical Marketing & Media;Apr2000, Vol. 35 Issue 4, p42 

    Focuses on the misuse of the United States Food and Drug Administration's (FDA) rules on reminder advertisements for drugs in the direct-to-consumer area. Exclusions to reminder advertisements; Disadvantage of reminder commercials; Violating firms presented by the FDA.

  • Lessons from cisapride.  // CMAJ: Canadian Medical Association Journal;5/01/2001, Vol. 164 Issue 9, p1269 

    Editorial. Comments on the warning system in Canada about adverse side effects of drugs. Case of cisapride, a drug prescribed for stomach disorders, which caused fatal cardiac arrhythmias; How Health Canada lagged behind the United States Food and Drug Administration (FDA) in warning...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics